By Janet Coulter, MSN, MS, RN, CCM, FCM
It started with a snore.
Not the gentle, almost endearing kind that makes you chuckle and nudge your partner. This was the kind that rattles bedroom doors, vibrates through walls, and has family members debating whether to call a plumber or a pulmonologist.
Enter Barbara, a 52-year-old with obesity, hypertension, type 2 diabetes, and “just a little fatigue.” She had tried weight-loss programs, nutrition counseling, and even joined a walking group, only to quit after two weeks because she felt “too tired to exercise.”
What was missed? You guessed it.
Obstructive Sleep Apnea.
Patients like Barbara often fail to thrive not because they lack motivation, but because their bodies are fighting an invisible nighttime battle against untreated sleep apnea. Obstructive sleep apnea (OSA) has wide-ranging consequences that directly affect health outcomes. It disrupts normal metabolic processes and alters appetite regulation. This contributes to persistent hunger and reduced satiety. Over time, these changes promote weight gain and insulin resistance, complicating the management of obesity and related chronic conditions. Individuals with untreated sleep apnea also experience mood disturbances, excessive daytime fatigue, and neurocognitive impairment. All of these can interfere with their quality of life and ability to perform usual roles and responsibilities. From a health risk perspective, untreated sleep apnea significantly increases the likelihood of cardiovascular disease. Importantly for professional case managers, untreated sleep apnea also undermines adherence to weight loss and lifestyle therapies. It creates a cycle in which poor sleep worsens metabolic health and reduces treatment adherence.
Understanding whether a sleep apnea case is complex or uncomplicated is critical to selecting the correct diagnostic pathway. In Barbara’s situation, the case is considered uncomplicated because there is no history of neuromuscular disease, stroke, or other conditions that significantly increase risk. Uncomplicated cases typically include the absence of major cardiorespiratory disease, neuromuscular weakness, chronic opioid use, wake hypoventilation, severe insomnia, or environmental barriers that could interfere with testing accuracy. These individuals are often appropriate candidates for home sleep apnea testing. In contrast, complex cases involve medical or neurologic comorbidities that raise the risk for nonobstructive sleep disorders and require a higher level of diagnostic evaluation. For case managers, selecting the appropriate sleep study is more than a routine referral decision. It is a form of risk triage that directly influences diagnostic accuracy, treatment selection, and downstream outcomes. Choosing the correct diagnostic test leads to timely intervention, improved adherence, and reduced likelihood of delayed or ineffective care.
Case Management Interventions
- Incorporate OSA screening in transitions of care for patients with obesity, hypertension, or diabetes.
- Advocate for simultaneous treatment of obesity and OSA (not sequential or siloed treatment).
- Educate patients on how treating OSA improves weight-loss success (better energy leads to higher activity).
- Identify suitable candidates for GLP-1 or dual agonist therapies.
- Promote early dietitian engagement and medical weight management planning.
- Encourage multidisciplinary team collaboration between sleep specialists, endocrinologists, pulmonologists, behavioral health, and primary care.
- Screen every adult with obesity for OSA as a standard practice.
- Keep patients engaged in the journey even when they’re too tired to care.
Polysomnography remains the preferred diagnostic modality for diagnosing sleep disorders. It is particularly appropriate for patients with complex clinical symptoms, suspected comorbid sleep disorders, or roles that involve safety-sensitive duties (such as operating heavy machinery) where diagnostic accuracy is critical. In contrast, home sleep apnea testing (HSAT) offers a simpler, more convenient, and cost-effective option. HSAT can be well-suited for clinically stable patients with a high likelihood of obstructive sleep apnea and no significant insomnia or complicated conditions. While HSAT can improve access and reduce barriers to testing, it may underestimate disease severity and is not appropriate when central sleep apnea is suspected. For case managers, understanding the different diagnostic modalities promotes informed decision-making and appropriate referrals. Access to both options continues to expand, particularly through durable medical equipment direct-to-home models, which allow for more timely diagnosis and streamlined care coordination.
Continuous positive airway pressure remains the clinical gold standard for treating obstructive sleep apnea, particularly in moderate-to-severe cases. It reliably improves the apnea–hypopnea index, daytime alertness, and overall quality of life. However, despite its effectiveness, CPAP can be personally burdensome for many patients. Not everyone likes the bling. Long-term adherence remains a significant challenge. Only an estimated 30 to 60 percent of individuals use the device as prescribed. In addition, CPAP primarily addresses nighttime airway patency and does not treat underlying contributors such as excess body weight or airway collapsibility. As a result, while CPAP may help patients breathe better during sleep, it does not always translate into improved functional capacity, energy, or mobility during waking hours.
A major development has been the introduction of tirzepatide as an FDA-approved treatment specifically indicated for adults with obesity and moderate to severe obstructive sleep apnea. Unlike prior therapies in which sleep improvement was a secondary benefit, this medication directly targets the condition itself. Clinical outcomes demonstrate improvements in apnea–hypopnea index, body weight, cardiometabolic risk, and patient-reported energy levels. This can positively influence treatment adherence and long-term outcomes. Importantly, tirzepatide is not a replacement for CPAP, but rather as a complementary therapy.
Don’t Ignore the Snore.
Behind every snore is a story and often a high-risk patient waiting to be heard. When obesity and OSA work together, the results can be devastating. But with timely identification, thoughtful coordination of care, and a dual-focused strategy, case managers can help patients reclaim control of their health and their nights.
Snoring may sound harmless, sometimes even comical, but for millions of patients, it’s a loud warning sign of a dangerous cycle. Obstructive sleep apnea (OSA) and obesity form a powerful and mutually reinforcing health challenge that professional case managers cannot afford to overlook. As incidences increase, the implications for long-term health, resource utilization, and quality of life intensify. Understanding the interplay between these two conditions is essential to developing patient-centered strategies that disrupt the cycle and support improved outcomes.
Sometimes solving a complex care challenge starts with simply asking: “How well are you sleeping?”
Case Manager Quick Screen: Ask Your Patient
- Do you snore loudly?
- Do you feel tired during the day?
- Has anyone witnessed you STOP breathing while you sleep?
- Do you struggle with weight management despite effort?
If yes to two or more, consider a sleep referral!
Who says professional development can’t feel like a vacation? This year, CMSA is turning Las Vegas into a Case Manager’s paradise! Think of the 2026 CMSA Annual Conference & Expo as the perfect blend of high-stakes education and oasis-level networking.
And take advantage of the early bird registration rate while it lasts. https://bit.ly/4pQ3GE5
Bio: Janet Coulter, MSN, MS, RN, CCM, FCM is President of CMSA. She is a transplant case manager with a wide variety of experiences including educator, administrator, team leader, and Director of Case Management. Janet holds a Master of Science in Nursing from West Virginia University and a Master of Science in Adult Education from Marshall University. She has published many articles in CMSA Today and the Professional Case Management Journal and served as a reviewer for the Core Curriculum for Case Management Third Edition. She has served as President-Elect of CMSA, Chair of the CMSA Today Editorial Board, Chair of the Nominations Committee, and Vice-President of the CMSA Foundation board. Janet was the recipient of the CMSA National Award of Service Excellence and Southern Ohio Valley CMSA Case Management Leadership award and was recently inducted as a Case Management Fellow from CMSA.